Cargando…

Tenosynovial giant cell tumor: case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature

BACKGROUND: Tenosynovial giant cell tumors (TGCTs) or giant cell tumors of tendon sheath are neoplasms that arise in the synovium. They can be categorized as nodular (localized) or diffuse type (D-TGCT). Historically, surgery has been the mainstay of therapy, but diffuse type disease recurs at a hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giustini, Nicholas, Bernthal, Nicholas M., Bukata, Susan V., Singh, Arun S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038319/ https://www.ncbi.nlm.nih.gov/pubmed/30002809 http://dx.doi.org/10.1186/s13569-018-0101-2

Ejemplares similares

Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis
por: Thongchot, Suyanee, et al.
Publicado: (2022)

A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel
por: Piawah, Sorbarikor, et al.
Publicado: (2019)

Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors
por: Gelderblom, Hans, et al.
Publicado: (2020)

Complementary Effects of Surgery and Pexidartinib in the Management of Patients with Complex Diffuse-Tenosynovial Giant Cell Tumor
por: Bernthal, Nicholas M., et al.
Publicado: (2022)

Pexidartinib (PLX3397) through restoring hippocampal synaptic plasticity ameliorates social isolation-induced mood disorders
por: Wang, Laifa, et al.
Publicado: (2022)

A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor
por: Rosenbaum, Evan, et al.
Publicado: (2019)

Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors
por: Wesolowski, Robert, et al.
Publicado: (2019)

Anti-Anaplastic Thyroid Cancer (ATC) Effects and Mechanisms of PLX3397 (Pexidartinib), a Multi-Targeted Tyrosine Kinase Inhibitor (TKI)
por: Luo, Jingtao, et al.
Publicado: (2022)

Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor
por: Monestime, Shanada, et al.
Publicado: (2020)

Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor
por: Yin, Ophelia, et al.
Publicado: (2021)

Pexidartinib Long‐Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors
por: Lewis, James H., et al.
Publicado: (2020)

Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations
por: Vaynrub, Anna, et al.
Publicado: (2022)

Population Pharmacokinetic Analysis of Pexidartinib in Healthy Subjects and Patients With Tenosynovial Giant Cell Tumor or Other Solid Tumors
por: Yin, Ophelia, et al.
Publicado: (2020)

Management of Tenosynovial Giant Cell Tumor: A Neoplastic and Inflammatory Disease
por: Healey, John H., et al.
Publicado: (2020)

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors
por: Gelhorn, Heather L., et al.
Publicado: (2016)

Distinguishing the effects of systemic CSF1R inhibition by PLX3397 on microglia and peripheral immune cells
por: Okojie, Akhabue K., et al.
Publicado: (2023)

Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial
por: Van De Sande, Michiel, et al.
Publicado: (2021)

Depletion of microglia with PLX3397 attenuates MK-801-induced hyperactivity associated with regulating inflammation-related genes in the brain
por: Ni, Rong-Jun, et al.
Publicado: (2023)

Suppression of Microgliosis With the Colony-Stimulating Factor 1 Receptor Inhibitor PLX3397 Does Not Attenuate Memory Defects During Epileptogenesis in the Rat
por: Wyatt-Johnson, Season K., et al.
Publicado: (2021)

Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development
por: Benner, Brooke, et al.
Publicado: (2020)

Psychometric properties of a custom Patient-Reported Outcomes Measurement Information System (PROMIS) physical function short form and worst stiffness numeric rating scale in tenosynovial giant cell tumors
por: Speck, Rebecca M., et al.
Publicado: (2020)

Tenosynovial Giant Cell Tumor of the Cervical Spine: Case Report and Review of the Literature
por: Thatikunta, Meena, et al.
Publicado: (2020)

Inhibition of Colony-Stimulating Factor 1 Receptor by PLX3397 Prevents Amyloid Beta Pathology and Rescues Dopaminergic Signaling in Aging 5xFAD Mice
por: Son, Yeonghoon, et al.
Publicado: (2020)

The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study
por: Bernthal, Nicholas M., et al.
Publicado: (2021)

Tenosynovial giant cell tumor: a case report
por: Ansel, Sonam, et al.
Publicado: (2023)

Localized tenosynovial giant cell tumor in children
por: Du, Xifeng, et al.
Publicado: (2023)

The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS)
por: Gelhorn, Heather L., et al.
Publicado: (2019)

Tenosynovial Giant Cell Tumor Arising on the Scapular Region
por: Fukuda, Asako, et al.
Publicado: (2013)

Diffuse Type Tenosynovial Giant Cell Tumor of the Ankle
por: Zhao, Jing-Jing, et al.
Publicado: (2016)

Cryosurgery as Additional Treatment in Tenosynovial Giant Cell Tumors
por: Verspoor, F. G. M., et al.
Publicado: (2016)

Chondroid Tenosynovial Giant Cell Tumor of Temporomandibular Joint
por: Shetty, Sujeeth Kumar, et al.
Publicado: (2018)

Intramuscular Tenosynovial Giant Cell Tumor, Diffuse-Type
por: Lee, Yoo Jin, et al.
Publicado: (2016)

Tenosynovial giant cell tumor of the distal tibiofibular joint
por: Zarate, Stephanie D., et al.
Publicado: (2021)

Tenosynovial giant cell tumor of the posterior pharyngeal space
por: Poutoglidis, Alexandros, et al.
Publicado: (2022)

Expanding the molecular spectrum of tenosynovial giant cell tumors
por: Gauduchon, Thibault, et al.
Publicado: (2022)

Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors
por: van IJzendoorn, David G.P., et al.
Publicado: (2022)

Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies
por: Palmerini, Emanuela, et al.
Publicado: (2023)

Pexidartinib: First Approval
por: Lamb, Yvette N.
Publicado: (2019)

Tenosynovial giant cell tumor of the cervical spine: a case report
por: Furuhata, Ryogo, et al.
Publicado: (2019)

Localized Giant Cell Tenosynovial Tumor Seen in the Knee Joint
por: Beytemür, Ozan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ihpncp13169p08eq54j8i6t702